MedPath

Reducing Heart Failure Re-admissions by Enhancing Sleep Apnea Treatment Adherence

Not Applicable
Completed
Conditions
Congestive Heart Failure
Sleep Apnea Syndromes
Interventions
Behavioral: AirCare App
Registration Number
NCT02312765
Lead Sponsor
University of Pennsylvania
Brief Summary

Sleep apnea, characterized by abnormal breathing at night, is often untreated in patients with heart failure. Helping patients to effectively use the most common form of treatment for sleep apnea, positive airway pressure therapy, can improve their heart function. This can reduce the likelihood that the patient will be re-admitted to the hospital. AirCareLabs has developed an innovative solution that allows patients to communicate with health care providers 24 hours a day, thus allowing them to get the help they need to effectively use positive airway pressure and thereby reduce the risk of being re-admitted to the hospital.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
146
Inclusion Criteria
  • Congestive heart failure and sleep apnea
Read More
Exclusion Criteria
  • Cognitive impairment
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
InterventionAirCare AppStudy participants will receive a tablet computer with the AirCare system.
Primary Outcome Measures
NameTimeMethod
Number of Participants Adhering to Positive Airway Pressure (PAP)one month

PAP adherence will be measured from the PAP unit (which monitors nightly hours of use and records this data; this is the standard of care clinical practice approach used currently by health care providers to monitor PAP use) and will be reported as Number of Participants who Adhered to Positive Airway Pressure (PAP) Treatment (adherence defined as \>4 hours of use per night on average across the 30 day period). For example, if 5 subjects used PAP for more than 4 hours per night on average across the 30 day period, then the number of adherent participants is 5.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath